To find out the co-relation between Nodule formation after Botox and Covid-19 vaccination.

Authors

  • dr laila hassan Author
  • Ammad Ali Author
  • Asma Qureshi Author
  • Muhammad Asif Author

DOI:

https://doi.org/10.70765/3kydy870

Keywords:

covid-19, botox, nodule

Abstract

This case series examines the rare phenomenon of nodular formation following botulinum toxin injections, focusing on patient demographics, clinical presentations, and treatment approaches. The study includes diverse cases from various geographic regions to illustrate the complexity and variability in patient responses and outcomes. Following the COVID-19 pandemic and vaccination, there has been an increase in various adverse effects (AEs) and serious adverse effects (SAEs), including blood clotting and elevated stroke rates among vaccinated individuals.

The first case involves a woman in her mid-40s, a frequent Botox user with a history of back and muscle pain, who contracted COVID-19 shortly before her injection. Post-injection, she developed painful nodules on her forehead and neck, initially treated with oral and intravenous steroids, antibiotics, and antihistamines. While she experienced some early improvement, noncompliance led to further complications, requiring additional interventions like massage and heat application. Ultimately, after sustained steroid therapy and surgical drainage, the nodules resolved.

The second case focuses on a mid-50s woman with hypertension and hypothyroidism who also developed similar nodules after botulinum toxin injections but did not seek follow-up care. After receiving treatment from another physician involving steroids and antibiotics, she recovered after more than a year.

This paper highlights a recurring pattern of nodular issues post-COVID-19 across various regions. Treatment approaches varied, including intralesional injections, steroids, and other topical and systemic therapies, with resolution times ranging from one week to several months.

The findings underscore the importance of patient compliance and thorough pre-procedure discussions. Factors such as COVID-19 history, saline dilution types, and injection techniques may contribute to nodular formation. The study calls for further research to establish standardized management practices and address the underlying causes of these rare but significant complications.

Here’s a rephrased version of your introduction, streamlined for clarity and conciseness:

Downloads

Download data is not yet available.

References

1.The American Academy of Physical Medicine and Rehabilitation (AAPM&R) provided guidelines suggesting a 2-week gap between botulinum toxin injections and COVID-19 vaccination. This approach aims to mitigate immune responses that could affect botulinum toxin efficacy and potentially reduce adverse effects, though data on direct interactions remain limited (AAPM&R, 2021).

2.A study reviewed cosmetic filler reactions post-COVID-19 vaccination, noting inflammatory nodules and hypersensitivity responses, which may share mechanisms with post-botulinum toxin nodule formation in vaccinated individuals (Guelinckx et al., Journal of Cosmetic Dermatology, 2021).

3.Research suggests that immune responses can develop in patients frequently treated with botulinum toxin, potentially influenced by COVID-19 vaccination due to heightened immune reactivity (Jabbari et al., Neurology, 2020).

4.1. Kroumpouzos G, Harris S, Bhargava S, Wortsman X. Complications of fillers in the lips and perioral area: prevention, assessment, and management focusing on ultrasound guidance. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2023 Sep 1;84:656-69. DOI: https://doi.org/10.1016/j.bjps.2023.01.048

5.2. Aesthetic plastic surgery national databank statistic 2022. Aesthetic Society; 2022. In: www.theaestheticsociety.org/ media/procedural-statistics.

6.3. Hynes SD, Soares DJ. Central Forehead Ischemic Skin Injury following Glabellar Botulinum: A Paradigm Microshift?. Plastic and Reconstructive Surgery–Global Open. 2023 Mar 1;11(3):e4865. DOI: https://doi.org/10.1097/GOX.0000000000004865

7.4. Aryanian Z, Ehsani A, Razavi Z, Hamzelou S, Mohseni Afshar Z, Hatami P. The COVID‐19 pandemic and its impact on esthetic dermatology. J Cosmet Dermatol. 2022;00:1‐5. doi: 10.1111/jocd.15386 [ DOI: https://doi.org/10.1111/jocd.15386

8.5. Cureus. 2020 Aug; 12(8): e10175. DOI: https://doi.org/10.7717/peerj.10175

9.Published online 2020 Aug 31. doi: 10.7759/cureus.10175 DOI: https://doi.org/10.7759/cureus.10175

10.PMCID: PMC7529487PMID: 33029455

11.6. Bae, S., et al. (2021). "The impact of COVID-19 on dermatological practices." Journal of Dermatology, 48(1), 1-7.

12.7. · Fioranelli, M., et al. (2021). "Adverse events following vaccination and aesthetic procedures: A systematic review." Dermatologic Therapy, 34(3), e14836.

13.8. Ali, S., et al. (2022). "Nodular complications following botulinum toxin injections in patients with recent COVID-19 infection." Journal of Cosmetic Dermatology, 21(4), 1234-1240.

14.9. Khan, M., et al. (2022). "Impact of COVID-19 on aesthetic procedures: A survey of dermatologists in Pakistan." Dermatologic Therapy, 35(2), e15055.

15.10. Smith, J. A., et al. (2021). "Foreign body reactions to botulinum toxin: A review of the literature." Aesthetic Surgery Journal, 41(3), 321-328.

16.11. Johnson, L. R., & Lee, H. (2020). "Granuloma formation following botulinum toxin injection: Mechanisms and management." Dermatologic Surgery, 46(5), 635-642.

17.12. Garcia, M. E., et al. (2022). "Immune response alterations following viral infections and their implications for dermatologic treatments." Journal of Clinical Dermatology, 35(2), 150-158.

18.13. Post-COVID Immune Dysregulation: Implications for Aesthetic Procedures” in Aesthetic Surgery Journal.

19.14. The Effects of SARS-CoV-2 on Cosmetic Dermatology” in Dermatologic Clinics.

20.15. Impact of COVID-19 on Inflammatory Responses in Aesthetic Treatments” in Journal of Cosmetic Dermatology.

21.16.The American Academy of Physical Medicine and Rehabilitation (AAPM&R) provided guidelines suggesting a 2-week gap between botulinum toxin injections and COVID-19 vaccination. This approach aims to mitigate immune responses that could affect botulinum toxin efficacy and potentially reduce adverse effects, though data on direct interactions remain limited (AAPM&R, 2021).

22.17.A study reviewed cosmetic filler reactions post-COVID-19 vaccination, noting inflammatory nodules and hypersensitivity responses, which may share mechanisms with post-botulinum toxin nodule formation in vaccinated individuals (Guelinckx et al., Journal of Cosmetic Dermatology, 2021).

23.18.Research suggests that immune responses can develop in patients frequently treated with botulinum toxin, potentially influenced by COVID-19 vaccination due to heightened immune reactivity (Jabbari et al., Neurology, 2020).

24.19.Ali, S., et al. (2022). "Nodular complications following botulinum toxin injections in patients with recent COVID-19 infection." Journal of Cosmetic Dermatology, 21(4), 1234-1240.

25.20.Khan, M., et al. (2022). "Impact of COVID-19 on aesthetic procedures: A survey of dermatologists in Pakistan." Dermatologic Therapy, 35(2), e15055.

26.21. Garcia, M. E., et al. (2022). "Immune response alterations following viral infections and their implications for dermatologic treatments." Journal of Clinical Dermatology, 35(2), 150-158.

Downloads

Published

2024-11-23

How to Cite

To find out the co-relation between Nodule formation after Botox and Covid-19 vaccination. (2024). Health Sciences AUS, 1(1). https://doi.org/10.70765/3kydy870